Story
Thanks for visiting this page. This time last year I took part in supporting Cure Leukaemia's Tour of the TAP challenge by running a 14km leg alongside Cure Leukaemia's CEO James McLaughlin
James who is 46 has taken on this crazy challenge again this year which means he will cover a 100 plus miles over a period of 14 days.
I'm still recovering from an injury but will be doing the challenge in a few weeks. In the mean time, I'm trying to assemble a super team of 100 friends and relatives to help me raise enough money to sponsor one leg & contribute to covering the full distance.
TAP, which stands for the Trials Acceleration Programme, consists of a network of specialist research nurses based in 12 of the UK’s biggest cities and including the Centre for Clinical Haematology (CCH) in Birmingham. TAP, which Cure Leukaemia made a 3-year £3,000,000 commitment to funding in January 2020, enables the accelerated setup and delivery of pioneering and potentially life-saving blood cancer clinical trials. The research nurses across the UK and the co-ordinating Hub allow these trials to run, giving patients from a catchment area of over 20 million people access to potentially life-saving treatments not currently available through standard care.